SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Guy is gaining traction as investors rally behind the restoration of iconic internet meme culture through its dedicated comic builder platform. The community is actively building on Solana, focusing on long-term conviction and original meme legacy rather than short-term market noise.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently a focal point for investors due to high network activity and the rapid proliferation of memecoin projects, which are driving significant community engagement and platform traffic. While some users express frustration with price volatility and market manipulation, others remain highly optimistic, viewing the current market cycle as an accumulation phase for long-term growth and institutional integration.

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing heightened investor attention following a significant revenue surge and progress on its domestic manufacturing strategy, despite recent volatility stemming from a short-seller report. Community sentiment remains mixed as traders debate the firm's growth potential versus operational risks, while discussions center on the company's ability to capitalize on AI-driven energy demand and U.S. solar infrastructure needs.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is in the spotlight as the community reacts to its recent FDA approval of Empaveli for the treatment of rare kidney diseases C3G and IC-MPGN, a major milestone that has sparked intense debate over the stock's future. Investors are heavily focused on whether this long-awaited regulatory win will serve as the necessary catalyst to reverse the company's recent downward trajectory and drive a meaningful growth turnaround.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors react to a debt retirement announcement involving bond-for-equity exchanges, which occurred alongside a defensive pushback against a critical short report targeting the company and its key holdings like BW. The community is actively debating the company's valuation, potential for a short squeeze, and the implications of a delayed 10-K filing as market participants watch for institutional movement and future earnings guidance.

"What's Updog?" is a Community Led token.

UpDog

The UpDog community remains highly active on social platforms, consistently driving engagement through humor-based wordplay and persistent project updates. Investors are currently focused on the token's long-term presence on the Solana network and its inclusion on major decentralized exchange strict lists as a key identifier of its community-driven momentum.

TOYO Co. Ltd. engages in the design, manufacture, and sale of solar cells and modules. It is involved in integrating the upstream production of wafer and silicon, midstream production of solar cell, downstream production of photovoltaic (PV) modules, and potentially other stages of the solar power supply chain. The company was founded on November 8, 2022 and is headquartered in Tokyo, Japan.

TOYO Co Ltd.

TOYO Co., Ltd

Investors are closely watching TOYO as it leverages its strategic U.S. manufacturing expansion and recent major supply contracts to position itself as a resilient, tariff-advantaged player in the solar sector. The community is actively discussing the company's compelling fundamental metrics, specifically its low forward P/E ratio and strong revenue growth, with many eyeing upcoming earnings and facility updates as key catalysts for a potential re-rating.

Maul Coin

Maul Coin is gaining rapid traction as a community-driven project, with investors actively discussing its potential for growth and the creator's transparency. The community is focused on pushing the token past bonding curve milestones and securing broader visibility through increased social media promotion.

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.

Centessa Pharmaceuticals plc - ADR

Centessa Pharmaceuticals PLC - ADR

Centessa Pharmaceuticals is experiencing significant market attention following the announcement that Eli Lilly will acquire the company for a total potential value of up to $7.8 billion. The community is actively discussing the strategic fit of Centessa's sleep-wake disorder pipeline within Lilly's existing neuroscience business and the potential implications of the included contingent value rights.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Greenwood Village, CO.

Brand Engagement Network Inc

Brand Engagement Network is generating significant market buzz as retail investors and community members track its intense short squeeze potential, fueled by high cost-to-borrow rates and a low float. Sentiment remains highly bullish among traders who are actively comparing the stock's recent price action to past multi-bagger runners, with many focusing on the impact of upcoming earnings and potential institutional support to drive further upward momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Niagen Bioscience, Inc. (NASDAQ:NAGE) Short Interest Down 13.6% in March

Niagen Bioscience, Inc. (NASDAQ:NAGE - Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 13th, there was short interest totaling 5,578,868...

Niagen Bioscience (NASDAQ:NAGE) Upgraded at Wall Street Zen

Wall Street Zen raised Niagen Bioscience from a "hold" rating to a "buy" rating in a research report on Saturday...

Niagen Bioscience Increases Share Repurchase Program to $20 Million

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors has...

Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen, Contributing to 45 Published Clinical Studies

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its external research...

Niagen Bioscience Launches Niagen Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud, From Tru Niagen Powered by Patented Niagen

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Niagen Skincare...

HC Wainwright Issues Optimistic Outlook for NAGE Earnings

Niagen Bioscience, Inc. (NASDAQ:NAGE - Free Report) - HC Wainwright increased their Q1 2026 earnings estimates for shares of Niagen Bioscience in a report released on Thursday, March 5th. HC...

Canaccord Genuity Group Cuts Niagen Bioscience (NASDAQ:NAGE) Price Target to $13.00

Canaccord Genuity Group dropped their price objective on Niagen Bioscience from $14.00 to $13.00 and set a "buy" rating for the company in a report on Thursday...

Niagen Bioscience Rallies 18% After Hours: Here's Why

Niagen Bioscience Inc. surged in after-hours trading after reporting record 2025 results, while maintaining a cautious outlook for 2026.read more...

Niagen Bioscience Doubles Annual Profit, CEO Signals Acquisition Hunt And GLP-1-Style Expansion Stock Jumps After-Hours (UPDATED)

NAD+ company Niagen Bioscience doubles profits in 2025, eyes acquisitions and new markets as the longevity market picks up momentum.read more...

Niagen Bioscience (NAGE) Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

iShares Dynamic Equity Active ETF ($BDYN)

Grayscale Bitcoin Trust ETF ($GBTC)

Destiny Tech100 Inc ($DXYZ)

Global X Defense Tech ETF ($SHLD)

The Modern Portfolio Builder. This award honors the fund that makes long-term investing easier, cheaper, or more effective for people who want to "set it and forget it."

NAGE
Niagen Bioscience Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NAGE News

NAGENiagen Bioscience Inc.